Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
02/06/202408:01GlobeNewswire Inc.Celldex Therapeutics Presents Data Demonstrating Profound Improvements in Angioedema in Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2024NASDAQ:CLDXCelldex Therapeutics Inc
02/06/202408:00Business WireZT Systems Announces ACX200 Solutions Featuring NVIDIA GB200 Grace Blackwell Superchips for Next-Generation Accelerated Computing
02/06/202408:00PR Newswire (Canada)Déclaration du premier ministre à l'occasion de la Journée des Forces armées canadiennes
02/06/202408:00PR Newswire (Canada)Statement by the Prime Minister on Canadian Armed Forces Day
02/06/202407:56GlobeNewswire Inc.NVIDIA Enables Real-Time Healthcare, Industrial and Scientific AI Applications at the Edge With Enterprise Software Support for NVIDIA IGX With HoloscanNASDAQ:NVDANVIDIA Corporation
02/06/202407:52GlobeNewswire Inc.NVIDIA Robotics Adopted by Industry Leaders for Development of Tens of Millions of AI-Powered Autonomous MachinesNASDAQ:NVDANVIDIA Corporation
02/06/202407:44GlobeNewswire Inc.Robotic Factories Supercharge Industrial Digitalization as Electronic Makers Adopt NVIDIA AI and OmniverseNASDAQ:NVDANVIDIA Corporation
02/06/202407:42PR Newswire (US)Bio-Thera Solutions Presents Clinical Data for BAT8006 (Folate Receptor-alpha-ADC) at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
02/06/202407:41GlobeNewswire Inc.NVIDIA Brings AI Assistants to Life With GeForce RTX AI PCsNASDAQ:NVDANVIDIA Corporation
02/06/202407:35GlobeNewswire Inc.Computer Industry Joins NVIDIA to Build AI Factories and Data Centers for the Next Industrial RevolutionNASDAQ:NVDANVIDIA Corporation
02/06/202407:32GlobeNewswire Inc.NVIDIA Supercharges Ethernet Networking for Generative AINASDAQ:NVDANVIDIA Corporation
02/06/202407:30Business WireDenodo Opens ME Regional Head Office in Kingdom of Saudi Arabia to Meet Growing Demand for Data Management and AI
02/06/202407:30Business WireDenodo Integrates NVIDIA NIM Inference Microservices to Accelerate and Optimize AI Capabilities for Enterprises
02/06/202407:30PR Newswire (US)Vention to democratize industrial automation using NVIDIA AI technologies
02/06/202407:30PR Newswire (US)Crimson Cup Coffee & Tea Publishes 2024 Guide on How to Start a Coffee Shop in California
02/06/202407:30PR Newswire (Canada)Message de la gouverneure générale et commandante en chef du Canada à l'occasion de la Journée des Forces armées canadiennes
02/06/202407:30PR Newswire (Canada)Message from the Governor General and Commander-in-Chief of Canada on Canadian Armed Forces Day
02/06/202407:13GlobeNewswire Inc.NVIDIA NIM Revolutionizes Model Deployment, Now Available to Transform World’s Millions of Developers Into Generative AI DevelopersNASDAQ:NVDANVIDIA Corporation
02/06/202407:11GlobeNewswire Inc.NVIDIA Releases Digital Human Microservices, Paving Way for Future of Generative AI AvatarsNASDAQ:NVDANVIDIA Corporation
02/06/202407:05Business WireIMFINZI® (durvalumab) is the first and only immunotherapy to show survival benefit in limited-stage small cell lung cancer in global Phase III trial, reducing the risk of death by 27% vs. placeboNASDAQ:AZNAstraZeneca PLC
02/06/202407:00Business WireENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a median progression-free survival of 13.2 months in HR-positive, HER2-low and HER2-ultralow metastatic breast cancer following one or more lines of endocrine therapyNASDAQ:AZNAstraZeneca PLC
02/06/202407:00GlobeNewswire Inc.CryptoHeap Launches Comprehensive Strategy for Crypto Staking Amidst Market Fluctuations
02/06/202407:00Business WireGilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal CancerNASDAQ:GILDGilead Sciences Inc
02/06/202407:00GlobeNewswire Inc.Intellia Therapeutics Announces Positive Long-Term Data from Ongoing Phase 1 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema (HAE)NASDAQ:NTLAIntellia Therapeutics Inc
02/06/202407:00GlobeNewswire Inc.William Miller Spearheads Launch of Pioneering OkayCoin Staking Protocol
02/06/202407:00Business WireMassive Bio and Mika Health Combine AI and Next-Generation Sequencing Biomarker Testing to Empower Cancer Patients On Treatment and Those Searching for and Participating in Clinical Trials in the United States and Europe
02/06/202407:00Business WireENHERTU® Demonstrated a Median Progression-Free Survival of 13.2 Months in HR Positive, HER2 Low and HER2 Ultralow Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy
02/06/202407:00PR Newswire (US)OncoHost Announces New Study on Biomarkers for Renal Cell Carcinoma
02/06/202406:45The Daily Hodl‘Hundreds of Trillions’– Sergey Nazarov Says 2024 Is Year Crypto and Global Financial System MergeCOIN:FETUSDFetch
02/06/202406:20PR Newswire (Canada)/R A P P E L -- Avis aux médias - Itinéraire de la vice-première ministre pour le dimanche 2 juin 2024/